➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKinsey
Medtronic
Dow
AstraZeneca

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

List of Excipients in API alectinib hydrochloride


Email this page to a colleague

« Back to Dashboard

Excipients in branded drugs containing alectinib hydrochloride

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Genentech, Inc. ALECENSA alectinib hydrochloride 50242-130 CARBOXYMETHYLCELLULOSE CALCIUM 2035-04-24
Genentech, Inc. ALECENSA alectinib hydrochloride 50242-130 CARNAUBA WAX 2035-04-24
Genentech, Inc. ALECENSA alectinib hydrochloride 50242-130 CARRAGEENAN 2035-04-24
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
Moodys
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.